The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment
Pan Zhang(China Pharmaceutical University), Meirong Huo(China Pharmaceutical University), Xuxin Chu(China Pharmaceutical University), Xinyuan Zhou(Chinese Academy of Sciences), Yongwei Gu(Shanghai Medical College of Fudan University), Nan Liu(Nanfang Hospital), Fangnan Lv(China Pharmaceutical University), Jianping Zhou(China Pharmaceutical University), Lifang Yin(China Pharmaceutical University), Jiyong Liu(Fudan University Shanghai Cancer Center), Chao Qin(University of Southern California)
Cited by 68
Related Papers
High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance
|Nature Communications|2021|269
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
|ACS Nano|2018|229
Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance
|British Journal of Cancer|2019|202
The Kinase IKKβ Regulates a STING- and NF-κB-Dependent Antiviral Response Pathway in Drosophila
|Immunity|2018|168
Two cGAS-like receptors induce antiviral immunity in Drosophila
|Nature|2021|149